Elliptic Laboratories ASA
OSE:ELABS
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
9.45
18.2
|
Price Target |
|
We'll email you a reminder when the closing price reaches NOK.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
Abbvie Inc
NYSE:ABBV
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Realty Income Corp
NYSE:O
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one ELABS stock under the Base Case scenario is 24.05 NOK. Compared to the current market price of 12.78 NOK, Elliptic Laboratories ASA is Undervalued by 47%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Elliptic Laboratories ASA
Run backtest to discover the historical profit from buying and selling ELABS based on its intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Price Target |
Loading
|
Revenue Forecast |
|
Operating Income Forecast |
|
Earnings Forecast |
|
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Elliptic Laboratories ASA
Balance Sheet Decomposition
Elliptic Laboratories ASA
Current Assets | 189.3m |
Cash & Short-Term Investments | 93.9m |
Receivables | 92.4m |
Other Current Assets | 3m |
Non-Current Assets | 167.1m |
PP&E | 18.5m |
Intangibles | 64.6m |
Other Non-Current Assets | 84m |
Current Liabilities | 25.7m |
Accounts Payable | 6.4m |
Other Current Liabilities | 19.4m |
Non-Current Liabilities | 13.2m |
Long-Term Debt | 13.2m |
Earnings Waterfall
Elliptic Laboratories ASA
Revenue
|
87.2m
NOK
|
Operating Expenses
|
-117.3m
NOK
|
Operating Income
|
-30.1m
NOK
|
Other Expenses
|
5.1m
NOK
|
Net Income
|
-25m
NOK
|
Free Cash Flow Analysis
Elliptic Laboratories ASA
NOK | |
Free Cash Flow | NOK |
Elliptic Labs reported a 51% increase in revenue, reaching NOK 56.1 million year-to-date 2024, driven by new contracts in the PC and laptop segments. EBITDA improved significantly to NOK 0.81 million from a negative NOK 12.2 million last year, with an EBITDA margin of 14.3%. The company signed two new contracts, including its first in the consumer laptop segment, highlighting strong market momentum. Operating expenses slightly decreased, and a positive operating cash flow of NOK 1.9 million was achieved. A strong cash position of NOK 97 million supports continued growth.
What is Earnings Call?
ELABS Profitability Score
Profitability Due Diligence
Elliptic Laboratories ASA's profitability score is 33/100. The higher the profitability score, the more profitable the company is.
Score
Elliptic Laboratories ASA's profitability score is 33/100. The higher the profitability score, the more profitable the company is.
ELABS Solvency Score
Solvency Due Diligence
Elliptic Laboratories ASA's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Score
Elliptic Laboratories ASA's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ELABS Price Targets Summary
Elliptic Laboratories ASA
According to Wall Street analysts, the average 1-year price target for ELABS is 22.44 NOK with a low forecast of 22.22 NOK and a high forecast of 23.1 NOK.
Dividends
Current shareholder yield for ELABS is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Elliptic Laboratories ASA operates as an AI virtual smart sensor platform. The company is headquartered in Oslo, Oslo. The company went IPO on 2020-10-16. The enterprise targets the smartphone, laptop, IoT, and automotive markets. The Company’s Artificial Intelligence (AI) software combines ultrasound and sensor-fusion algorithms to deliver intuitive 3D gesture and presence sensing experiences. Elliptic Laboratories ASA has offices in San Francisco, Oslo and Shanghai.
Officers
The intrinsic value of one ELABS stock under the Base Case scenario is 24.05 NOK.
Compared to the current market price of 12.78 NOK, Elliptic Laboratories ASA is Undervalued by 47%.